Jimmy Dore speaks with epidemiologist Nicolas Hulscher about an observational study of 200 cancer patients showing that 84.4% benefited from taking ivermectin and fenbendazole for six months, with 32.8% reporting no evidence of disease, 15.6% tumor regression, and 36% cancer stabilization. Hulscher explains that ivermectin targets cancer stem cells—which chemotherapy leaves behind, causing cancer to return—and has over 14 distinct anti-cancer mechanisms across more than 12 cancer types, including inducing apoptosis, cutting off angiogenesis, and disrupting microtubules.
Jimmy shares his personal experience of being vaccine-injured and treated with ivermectin, noting that the medical establishment lied about the drug to fast-track COVID vaccine approval for hundreds of billions in profit. He argues that no government or university will fund randomized trials because ivermectin and fenbendazole cannot be patented, while standard chemotherapy averages $111,000 per year and is highly toxic, something Dr. John Campbell describes as a "complete tragedy" for cancer patients.
No comments:
Post a Comment